FiercePharmaPolitics—Democrats honor Cummings with pricing bill by Eric Sagonowsky Monday, October 21, 2019 The U.S. lost a drug-pricing watchdog last week as Rep. Elijah Cummings died at age 68, and Democrats are naming their wide-ranging bill after him.
Teva shares approach 20-year low amid Moody's warning by Arlene Weintraub Thursday, August 15, 2019 Debt-rating firm Moody's revised its Teva outlook from "stable" to "negative" as the company deals with multiple challenges.
Lawmakers press Teva, Mylan for drug-pricing answers by Eric Sagonowsky Wednesday, August 14, 2019 Congressional pharma watchdogs are renewing an earlier request for drug-pricing information, saying three companies might've broken federal law.
U.S. reps question Gilead's donation of free HIV drug Truvada by Arlene Weintraub Thursday, June 27, 2019 U.S. Rep. Elijah Cummings is leading an effort to determine if Gilead's largesse is tied to its efforts to protect Truvada's patents.
Gilead's O'Day takes congressional hot seat to defend Truvada by Eric Sagonowsky Friday, May 17, 2019 Gilead's Truvada for PrEP is only getting to about 10% of people who could benefit, according to testimony Thursday.
GOPers urge drug chiefs to ignore Democrat's drug pricing probe by Eric Sagonowsky Tuesday, April 9, 2019 Two Republican lawmakers advised drugmakers to not participate in a drug pricing probe in a House committee.
Republicans and Democrats unite with Trump on pledge to lower drug prices by Arlene Weintraub Wednesday, January 30, 2019 A bipartisan push to lower drug prices could threaten the industry's ability to drive earnings growth, some analysts warn.
Vermont thumbs its nose at Trump with drug import bill by Eric Sagonowsky Thursday, May 17, 2018 Vermont lawmakers took it upon themselves to pass a bill allowing drug imports from Canada. The catch? It'll need an OK from the Trump administration.
Democrats get out ahead of Trump's pricing speech by Eric Sagonowsky Thursday, May 10, 2018 President Donald Trump's big speech on drug prices is set for Friday, but Democrats talked up their own proposals Thursday.
Lawmakers push ahead with Medicare negotiation plan by Eric Sagonowsky Wednesday, October 25, 2017 Even though drug pricing talk in Washington, D.C., has quieted somewhat, a group of lawmakers continue to beat the drum for reform.
